Emergen research’s latest document, titled ‘Biodefense market’ is one of the most sought-after market reports involving an in-depth analysis of the global Biodefense market. The report’s authors have offered necessary details on the latest Biodefense market trends and the crucial parameters impacting both short-term and long-term market growth.
The global biodefense market size is expected to reach USD 20.13 Billion in 2028 and register a revenue CAGR of 5.4% over the forecast period, according to the latest report by Emergen Research. Favorable government initiatives, increasing possibility of biological threats and attacks are factors driving global biodefense market revenue growth.
Biodefense is the use of medical measures to protect citizens against bioterrorism threats or possibility. Biodefense also includes production of stockpiles of vaccines and medication for people across the globe. Bioterrorism is an intentional release of harmful biological agents such as bacteria, viruses, and other germs to cause sickness/illness, and to harm humans, animals, or crops in a country or region. Biological agents can spread through air, water, food, and contact, and can ruin food crops and infect or kill livestock to terrorize populations or to manipulate governments.
Click the link to get info@ https://www.emergenresearch.com/industry-report/biodefense-market
Key Points of Biodefense Market:
- Extensive coverage of the analysis of the Biodefense market
- Key insights into the regional spread of the industry in key geographies
- Radical insights into the vital market trends; both current and emerging trends, and factors influencing the growth of the Biodefense market
- Comprehensive coverage of the impact of the COVID-19 pandemic on the overall growth of the Biodefense market
- Complete data about the key manufacturers and vendors in the Biodefense market
Major companies included in the global market report are CanSino Biologics, BioNTech SE, Altimmune, Emergent BioSolutions Inc., SIGA Technologies, Inc., Cleveland BioLabs, Inc., Alnylam Pharmaceuticals Inc., Elusys Therapeutics, DynPort Vaccine Company LLC, and Ichor Medical Systems Inc., AstraZeneca Plc, Serum Institute of India, Wuhan Institute of Biological Products, Inovio Pharmaceuticals Inc., and SinovacBiotech Ltd.
Radical Highlights of the Biodefense Market Report:
- Comprehensive overview of the Biodefense market along with analysis of the changing dynamics of the market
- Growth Assessment of various market segments throughout the forecast period
- Regional and global analysis of the market players, including their market share and global position
- Growth strategies adopted by key market players to combat the impact of the COVID-19 pandemic on the market
- Impact of the technological developments and R&D advancements on the Biodefense market
- Information about profit-making strategies and developmental strategies of major companies and manufacturers
- Insightful information for the new entrants willing to enter the market
Emergen Research has segmented the global biodefense market on the basis of product type, biothreat detection device type, end-use, and region:
Product Type Outlook (Revenue, USD Billion; 2018–2028)
- COVID-19 Vaccine
- Anthrax Vaccine
- Smallpox Vaccine
- Botulism Vaccine
- Others
Biothreat Detection Device Type Outlook (Revenue, USD Billion; 2018-2028)
- Sampler
- Triggering Devices
- Identifier
- Others
End-use Outlook (Revenue, USD Billion; 2018–2028)
- Hospital and Clinics
- Ambulatory Care Centre
- Research Organizations
- Military
- Others
Some Key Highlights from the Report
- Smallpox vaccine segment accounted for significantly large revenue share in 2020 and is expected to register a rapid growth rate during the forecast period. Smallpox vaccine is made from vaccinia virus, which is less harmful to human body and protects by helping the body to develop immunity.
- Identifier segment accounted for large revenue share in 2020 owing to rapid increase in biological threats. Identifier is a device, which detects biological agents with high accuracy. The information obtained from the identifier is used to determine protection requirements and treatment of exposed personnel.
- Market in North America accounted for largest revenue share in 2020 owing to increase in supportive government initiatives along with explicit biodefense strategies adopted by the U.S in order to stockpile sufficient vaccines.
Thank you for reading our report. Customization of the report is available. To know more, please connect with us, and our team will ensure the report is customized as per your requirements.
Take a Look at our Related Reports:
next-generation sequencing market
in-vitro fertilization market
companion diagnostics market
ai-based sensors market
follicular lymphoma treatment market
blockchain in healthcare market
next generation sequencing sample preparation market
pharmacogenomics market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
